45291_54786de3c16dda2ae6786d0429eb2baf3b36391b

info@avantiascience.com

AVANTIA LIMITED

AVANTIA LIMITED

Contact

Contact

Company details

AVANTIA LIMITED

Company No. 125066 (Gibraltar)

Suite 4, 2nd Floor, The West Wing

Montarik House, 3 Bedlam Court

Gibraltar GX11 1AA

info@avantiascience.com

info@avantiascience.com

Expert consulting in biomedicine, molecular diagnostics and translational medicine, and supply of materials and technologies for research and development.

AVANTIA LIMITED

Scientific and regulatory consulting for companies developing diagnostics, medicines and health data tools, and supply of specialised materials and technologies for research and development.

45291_c5aa03afd16ba2d4bebdf31cbc23e484b78d91cc

About us

AVANTIA LIMITED is a biomedical research and development consultancy led by a recognised scientist in molecular and translational medicine, with long experience in oncology research, biomarker development and the translation of laboratory findings into clinical practice. We work with a network of specialists in clinical research, diagnostics, regulatory affairs, biostatistics and medical communication, who join individual projects as the brief requires.

 

We are not a contract research organisation and do not run laboratories or clinical sites. We advise, design and write, working alongside our clients' own teams and partners. Every engagement is defined in a written proposal with agreed scope, deliverables, timeline and price.

45291_e49099e2a272828d17cc91983ed7575535e84a1f

Services

Study design and protocols. Design of research and clinical studies, from multi-omic biomarker discovery and biomarker validation to observational and interventional studies. We prepare the study proposal, protocol, endpoints and analysis plan so that the study answers the question it was commissioned for.

 

Scientific and regulatory advice. Development strategy for medicinal products, in vitro diagnostics and software processing biomedical data: evidence requirements, clinical performance studies, IVDR classification and what regulators and payers will expect to see.

 

Expert content and education. Programmes and lectures for scientific conferences and continuing medical education, and expert content for public health communication on cancer prevention, healthy lifestyle and nutraceuticals.

 

Research materials and technologies. Sourcing and supply of high-purity ingredients, chemicals, reagents, laboratory devices and technologies for research and development, including cosmetic-grade active substances, with identification of suitable manufacturers and technologies available for distribution in Central Europe.